Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by CancerSlayeron Oct 28, 2021 5:37pm
307 Views
Post# 34060896

RE:RE:We are # 1

RE:RE:We are # 1

gonefishing2022 wrote:
Not Much Posting,Everyone just checking for the halt or the News any Day now

 

Yep, simply a waiting game for enough data that would support a BTD...just 3 more patients is the goal/hope.  I'm just as eagerly awaiting news on the vaccine front.  This could be an even bigger news event.  However, my guess is such news will likely take significantly longer to come by.  I'd expect a more extended timeline if they are in the process of developing a better, more novel vaccine adjuvant.  The goal is to not only stimulate a maximal immune response, whether it be against a type of infection or cancer, but to also activate a "better" response compared to the strong competition.  Development of a novel & superior vaccine/adjuvant can be a slooow process, but ultimately worth it if successful & done with the right partner (which we have in LKSKI imo) & within budget.  

A selfish scientific aside...would be interesting to see the new lab investigate the use of mesoporous silicon nanoparticles as vaccine adjuvants...the larger-pore nanoparticles have shown some promise preclinically in boosting the immune response against some bad actors via the ability to present a higher concentration of antigen for a longer period of time right where it counts...as has recently been demonstrated in a GBM tumor model.
 

Issue 2, 2021

Immunostimulatory silica nanoparticle boosts innate immunity in brain tumors


<< Previous
Bullboard Posts
Next >>